Jia Shen Tablet vs Shenfu injection
Same mechanism, same race: design-graded trial evidence for both assets, with the grading rationale shown. Grades describe the quality of the evidence, never the merits of either security.
Heart Failure
Shared mechanism: Multi-target (ginsenoside) · full Heart Failure pipeline
Jia Shen Tablet
Developed by Tasly Pharmaceutical Group
NCT06348498 · Phase 1 · status unknown
This is a small, single-arm, open-label study of 18 people with chronic heart failure, designed to characterize the drug's pharmacokinetics rather than to test whether it works against a comparator, and no results have been posted.
Next expected readout: December 2026 · NCT06669169 (registry estimate)
No aligned efficacy figure on record for this race.
Shenfu injection · Shenfu Zhusheye
Marketed by China Resources Sanjiu Medical & Pharmaceutical
No graded featured trial for this indication yet; the grade above reflects that absence, not a judgment.
No aligned efficacy figure on record for this race.
Results for Heart Failure
Values come from each drug's own ClinicalTrials.gov study. They are from separate trials and patient populations, not a head-to-head comparison. Each result identifies its source trial, phase, arm and timepoint; limitations that apply to a whole cell are marked with a letter and listed once beneath the table. The comparison is deepest for later-stage drugs (phase 3 or approved), which usually have posted results to draw on; early-stage drugs often have none yet.
| Key endpoint | Jia Shen Tablet | Shenfu injection |
|---|---|---|
| CV death or HF hospitalisation | —Not reported | —Not reported |
| HF hospitalisation | —Not reported | —Not reported |
| CV death | —Not reported | —Not reported |
| KCCQ clinical summary, change | —Not reported | —Not reported |
CV death or HF hospitalisation
- Jia Shen Tablet
- —Not reported
- Shenfu injection
- —Not reported
HF hospitalisation
- Jia Shen Tablet
- —Not reported
- Shenfu injection
- —Not reported
CV death
- Jia Shen Tablet
- —Not reported
- Shenfu injection
- —Not reported
KCCQ clinical summary, change
- Jia Shen Tablet
- —Not reported
- Shenfu injection
- —Not reported
- Each cell is from that drug's own trial. Trials differ in population, design and timepoint; this is not a head-to-head comparison.
- An empty cell names why: Not posted (a completed Phase 3 here has no posted results yet), Trial running, Pending review (we hold the result and are checking it) or Not reported.
Jia Shen Tablet: no structured comparison results are available for Heart Failure.
Shenfu injection: no structured comparison results are available for Heart Failure.
The full competitive landscape for each asset (every same-race competitor with aligned evidence, sortable) is on the asset pages: Jia Shen Tablet's landscape · Shenfu injection's landscape